Cargando…
Melatonin drugs inhibit SARS-CoV-2 entry into the brain and virus-induced damage of cerebral small vessels
COVID-19 is a complex disease with short- and long-term respiratory, inflammatory and neurological symptoms that are triggered by the infection with SARS-CoV-2. Invasion of the brain by SARS-CoV-2 has been observed in humans and is postulated to be involved in post-COVID state. Brain infection is pa...
Autores principales: | Cecon, Erika, Fernandois, Daniela, Renault, Nicolas, Coelho, Caio Fernando Ferreira, Wenzel, Jan, Bedart, Corentin, Izabelle, Charlotte, Gallet, Sarah, Le Poder, Sophie, Klonjkowski, Bernard, Schwaninger, Markus, Prevot, Vincent, Dam, Julie, Jockers, Ralf |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9191404/ https://www.ncbi.nlm.nih.gov/pubmed/35697820 http://dx.doi.org/10.1007/s00018-022-04390-3 |
Ejemplares similares
-
Melatonin Target Proteins: Too Many or Not Enough?
por: Liu, Lei, et al.
Publicado: (2019) -
Detection of SARS-CoV-2 spike protein binding to ACE2 in living cells by TR-FRET
por: Cecon, Erika, et al.
Publicado: (2021) -
SARS-COV-2 spike binding to ACE2 in living cells monitored by TR-FRET
por: Cecon, Erika, et al.
Publicado: (2022) -
Simufilam Reverses Aberrant Receptor Interactions of Filamin A in Alzheimer’s Disease
por: Wang, Hoau-Yan, et al.
Publicado: (2023) -
Leptin brain entry via a tanycytic LepR:EGFR shuttle controls lipid metabolism and pancreas function
por: Duquenne, Manon, et al.
Publicado: (2021)